<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endoscopic resection has become a major curative treatment for early colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> without lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, a poor prognostic factor in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, occurs in about 10% of the patients with submucosal invasive colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, it is important to identify a high-risk factor for lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in submucosal invasive colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This study was designed to identify the relationship between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding with β-catenin expression and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in submucosal invasive colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We investigated the immunohistochemistry of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding in the 142 patients who underwent surgical resection for submucosal invasive colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> between 1984 and 1999 and the expression pattern of β-catenin in budding <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Accordingly, <z:hpo ids='HP_0000001'>all</z:hpo> the patients were followed up for at least 10 years or until <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Among the 142 patients, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was detected in 14 patients (9.9%) </plain></SENT>
<SENT sid="7" pm="."><plain>Univariate analysis showed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding with ≥ 5 tumor cells or cell clusters with expression of β-catenin in the nucleus was significantly associated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P = 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding detected by <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin staining was not associated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate logistic regression analysis showed that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding with ≥ 5 tumor cells or cell clusters with expression of β-catenin in the nucleus was a significant risk factor for lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (odds ratio, 7.124; 95% confidence interval, 1.407-36.062) </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding associated with β-catenin expression is a risk factor for lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in submucosal invasive colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>